Artera commits $90 million to personalize prostate cancer treatment

California-based Artera, which offers an artificial intelligence-enabled test designed to personalize therapy for prostate cancer patients, announces its launch along with a $90 million investment.

Johnson & Johnson, TIME Ventures, Koch Disruptive Technologies, Coatue, Walden Catalyst Ventures, The Factory and Breyer Capital participated in the round along with angel investors Amarjit Gill, Clarence So, Marc Benioff, Lip-Boo Tan, Dennis Wong, Andy Jacques , Jim. Breyer, Jeff Dean, Chris Re, Steve Blank and Michael Driscoll.

WHAT ARE THEY DOING

Artera’s AI-powered multimodal test for prostate cancer patients, called the ArteraAI Prostate Test, helps predict potential therapy benefits and patient prognosis by analyzing patient clinical data and biopsy images.

The company will use the funds to expand its prostate cancer test and develop tests to help personalize treatment options for other cancers.

“Over the past 18 months, Artera’s AI-powered personalized cancer treatment approach has opened up commercial and regulatory opportunities far ahead of genomic competitors,” Coatue partner Stephen Cho said in a statement. “We are very pleased to support Artera as a pioneer in computer diagnostics for an important therapeutic area.”

MARKET REVIEW

According to the CDC, about 13 out of 100 American men will develop prostate cancer in their lifetime, and two out of three men will die from prostate cancer. African American men and those with a family history are more prone to prostate cancer than other men.

Another digital healthcare company looking to improve patient outcomes for prostate cancer is Avenda Health, which offers clinical decision support software. In November, the company received FDA 510(K) approval for its iQuest tool, designed to be used with MRI and biopsy results to help doctors provide more accurate cancer treatments.

Content Source

Dallas Press News – Latest News:
Dallas Local News || Fort Worth Local News | Texas State News || Crime and Safety News || National news || Business News || Health News

Related Articles

Back to top button